Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trypsin-Chymotrypsin vs Naproxen for Post-Endodontic Pain
NCT06562816Phase 4Recruiting
- Sponsor
- Dow University of Health Sciences
- Start
- Aug 2024
- Primary completion
- Nov 2024
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of trypsin + chymotrypsin (2 arms), sponsored by Dow University of Health Sciences. Primary endpoint: Change in post-endodontic treatment pain score using Numeric Rating Scale at 24 hours. Started Aug 2024; status: recruiting.
02
Drugs
trypsin + chymotrypsin
Beyond the preview
Go deeper on NCT06562816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06562816.